Description
Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial dysregulation (0.56), GFAP reactive astrocytosis (0.536). Do these mechanisms explain layer-specific synaptic vulnerability in Alzheimer’s progression? [TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402] [BUNDLE: data/analysis_outputs/analysis-SEAAD-20260402/mechanistic_de/bundle.json]
[TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402]
[FOLLOW-UP c2035b28] Agora debate queued via gap-20260410-094512 for full 4-round debate. Original debate quality was 0.65 (3 rounds only, missing Skeptic and Expert). Bundle from computational_biologist agent.
Resolution criteria
Gap resolved when: (1) Functional validation experiments confirm that at least 3 of the 5 identified differential expression hits (C1QA layer gradient, TREM2 DAM upregulation, VGLUT1 loss, APOE4 glial dysregulation, GFAP astrocytosis) are causal rather than correlative using CRISPRi/a or conditional KO in humanized AD mouse models; (2) A single-cell mechanistic atlas (≥100K nuclei, ≥8 cortical layers) maps these expression changes to specific disease stages (Braak I–VI), defining layer-specific vulnerability with ≥80% cell-type classification accuracy; (3) The atlas links each validated mechanism to ≥1 synaptic integrity readout (synaptophysin density, PSD-95 puncta) and the findings are incorporated into the SEA-AD analysis artifact.